Ignite Creation Date:
2024-05-06 @ 7:50 AM
Last Modification Date:
2024-10-26 @ 11:53 AM
Study NCT ID:
NCT02616848
Status:
UNKNOWN
Last Update Posted:
2015-11-30
First Post:
2015-11-21
Brief Title:
Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers
Sponsor:
Istituti Ospitalieri di Cremona
Organization:
Istituti Ospitalieri di Cremona
Organization Data
Organization:
Istituti Ospitalieri di Cremona
Class:
OTHER
Study ID:
2014-000135-17
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Istituti Ospitalieri di Cremona
Lead Sponsor Class:
OTHER
Responsible Party:
Giandomenico Roviello
Responsible Party Title:
MD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Istituti Ospitalieri di Cremona
Old Name:
None
Old Organization:
None